Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00691717 · ClinicalTrials.gov registry record · Phase 2
Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension
A Phase 2 study of Open Angle Glaucoma and Oular Hypertension, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 201
- Enrollment target
- 1
- Study location
NCT00691717: Completed Phase 2 study of Open Angle Glaucoma and Oular Hypertension, sponsored by Alcon Research.
NCT00691717 is a Phase 2 study of Open Angle Glaucoma and Oular Hypertension that has completed, run by Alcon Research. The registered enrollment target is 201 participants, below the 327-participant average among 28 other Open Angle Glaucoma trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00691717, a Phase 2 study of Open Angle Glaucoma and Oular Hypertension, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 201 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study was to evaluate the safety and intraocular-lowering efficacy of anecortave acetate depot when administered by anterior juxtascleral depot (AJD) for the treatment of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
Conditions Studied
Interventions
- DRUG Anecortave Acetate Sterile Suspension, 30 mg/mL
- DRUG Anecortave Acetate Sterile Suspension, 60 mg/mL
- OTHER Anecortave Acetate Vehicle
- DRUG Anecortave Acetate Sterile Suspension, 75 mg/mL
Study Locations (1)
South Carolina
- Charleston - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2008-06 |
| Est. Completion | 2009-09 |
| Phase | Phase 2 |
What the finished NCT00691717 record still lists
NCT00691717 is an interventional study that assigns participants to a tested intervention. The registered 201 participants enrollment target is mid-sized for trials with a published cap, below the 327-participant average among 28 other Open Angle Glaucoma trials with a reported enrollment target (39% lower).
The record links to 2 conditions, with Open Angle Glaucoma appearing as the primary indexed condition, and to 4 interventions - of which Anecortave Acetate Sterile Suspension, 30 mg/mL is the first listed.
NCT00691717 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT00691717 about?
NCT00691717 is a clinical study titled "Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension". The purpose of this study was to evaluate the safety and intraocular-lowering efficacy of anecortave acetate depot when administered by anterior juxtascleral depot (AJD) for the treatment of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
What is the current status of trial NCT00691717?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 201 participants. The study started on 2008-06. Estimated completion is 2009-09.
What conditions does trial NCT00691717 study?
This clinical trial studies the following conditions: Open Angle Glaucoma, Oular Hypertension.
What interventions are being tested in trial NCT00691717?
The interventions under investigation include: Anecortave Acetate Sterile Suspension, 30 mg/mL (DRUG), Anecortave Acetate Sterile Suspension, 60 mg/mL (DRUG), Anecortave Acetate Vehicle (OTHER), Anecortave Acetate Sterile Suspension, 75 mg/mL (DRUG).
Who is sponsoring clinical trial NCT00691717?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00691717 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Open Angle Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00691717's enrollment target sits among peer trials
201 13th of 28 higher than 16 of 28 other Open Angle Glaucoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Open Angle Glaucoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A 28 Day Study of ONO-9054 Ophthalmic Solution in Subjects With Ocular Hypertension (OHT) or Open-angle Glaucoma (OAG)
COMPLETED · Phase 2
-
24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients
RECRUITING · Phase 4
-
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
RECRUITING · NA
-
Efficacy of Simbrinza and Rocklatan vs Cosopt and Latanoprost
RECRUITING · Phase 4
-
Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma
RECRUITING · Phase 4
-
A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04422652 · 201 participants · Phase 2
Combination of Novel Therapies for CKD Comorbid Depression
- NCT05327114 · 201 participants · Phase 2
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- NCT06099769 · 201 participants · Phase 2
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
- NCT06274528 · 201 participants · Phase 2
DORA and LP in Alzheimer's Disease Biomarkers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia